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Introduction
Fibrodysplasia ossificans progressiva, previously called myositis ossificans progressiva, is a rare
genetic condition, inherited as an autosomal dominant disorder with variable penetrance. Most affected
patients appear to have had spontaneous mutations. The incidence of this disorder is low, less than I per
1,000,000 members of the population1.
Initially the patient presents clinically with soft tissue swellings, often in the neck and occiput, back,
shoulder, over the scapula and proximal parts of the limbs. These soft tissue swellings are oedematous
muscle or swelling of a localized group of muscles. These local or diffuse swellings may regress, or
may progress to ossification, It is not known that how often the lesions subside spontaneously and how
often the ectopic bone formation follows2. Remissions and relapses occur during the course of the
disease. Heterotopic ossification begins at a mean age of 5 years. Progressive involvement leads to
extensive immobility and eventual disability.
Bilateral congenital abnormalities of the great toes is very characteristic of fibrodysplasi a ossificans
progressiva, seen in more than 90% of patients. Virtually all patients have abnormally shortened great
toes, hallux valgus or both. Some patients may have short first metacarpals3,4.
Radiologically there is malformed first metatarsals which are usually elongated with medial angulation
distally. The hypoplasia of the articulating proximal phalanx results
in hallux valgus deformity. Often both first metacarpals are hypoplastic. These characteristic skeletal
findings in association with the fibrous soft tissue mass is diagnostic of fibrodysplasia ossificans
progressiva5.
Laboratory study results are normal, except for mild elevation of serum alkaline phosphatase levels
during early periods of heterotopic ossification1. The only laboratory finding is an elevated eosinophil
count6.
The pathophysiology of this disorder is not clear. It has been postulated that there is defective
regulation of the induction of endochondral ossification as the predominant pathogenetic mechanism of
this disorder1. Most of the patients may survive well into adulthood but with marked disability. Many
of them die as a consequence of restrictive lung disease from ankylosis of the ribs.
The aim of the treatment is to prevent the formation of ectopic bone which causes ankylosis of joints
and progressive immobility. Various modalities of treatment have been tried, such as steroids, mineral
binding agents or calcification blocking agents such as ethylene-diamin-tetraacetate (EDTA), but all
without success2.
Disodium ethydronate (ethane-Hydroxy-1, 1-diphosphonate or EHDP) has been used in the treatment
of fibrodysplasia ossificans progressiva to prevent mineralization of areas of active myositis or the
remineralization after surgical removal of established ectopic bone2,7-9. Some authors have clearly
established some beneficial effect of EHDP on acute progressive cases of fibrodysplasia ossificans
progressiva but no demonstrable beneficial effect on the extensive and stabilised lesion. They have
found that, most of the newly formed soft tissue swellings regressed within a few days without any
evidence of calcification on subsequent x-rays7. L. Bruni et al in 1990 have shown very encouraging
results with disodium ethydronate (EHDP) in an 11 year old child with marked disability10. At present,
disodium ethydronate

(EHDP) is the only agent that has proved to be some how beneficial in such cases.
Case Report
The patient was a 3 year old female child, a product of a normal, full term pregnancy and a normal
delivery. Birth weight is not known as the child was born at home. The child is the last sibling, has two
elder brothers aged 11 years and 5 years and one sister who is 7 years old. All of them are normal and
healthy. The child’s parents are Second cousins and both of them are healthy. The child did not suffer
from any neonatal complications. Her developmental history was normal.
At the age of 3 months mother had noticed for the first time a swelling over the occiput. There was no
history of trauma or injury or any associated constitutional symptoms. Within few weeks, few more
soft tissue rtiasses appeared near the occiput and moved gradually towards the mastoid process. The
mother had taken the child to a hospital where she was reassured that the child has cephalohaematoma
which will resolve. Swellings had regressed to some extent and no more new swellings appeared until
two months ago, when the swelling over the occiput reoccurred and two more appeared over the
parietal region. Within few weeks the child developed more swellings over left side of the neck and
shoulder and upper part of back. Because of the swelling at the neck the range of neck movements was
restricted. Again the parents took the child to the same hospital, where x-rays of skull and some
laboratory tests were done. Coagulation disorder, cellulitis and rickets were considered in the
differential diagnosis. She was reated at this Hospital with various antibiotics. As the swellings,
continued to increase, and a conclusive diagnosis could not be ascertained her parents brought the child
to the Aga Khan University Hospital Karachi for further assessment and treatment.
The physical Examination, showed a 3 year old female child, weighing 12.8 kg with a height of 92 cm.
The muscles in the neck and the upper part of the back were swollen and firm to hard in consistency
and she had limited neck movements. No swellings were noted in upper or lower limbs and neither at
lower back. Her respiratory, cardiovascular and abdominal examinations were all unremarkable. She
had bilateral short great toes with valgus deformity (Figure 1).

Her soft tissue swellings which were bony hard as if ectopic bone had formed and bilateral abnormal
great toes provided the initial clue towards the diagnosis of fibrodysplasia ossificans progressiva. Plain
radiographs of soft tissue swelling of skull, neck, feet and hands were ordered. Some laboratory tests
were also done.

Laboratory Findings. Her haemoglobin was 9.8 gm/dl and haematocrit of 30.9%. She had raised
eosinophil count of 10% (n.y. 01 - 06 %) and her serum calcium, phosphorus and alkaline phosphatase
were all within normal limits.
Radiological Findings. Plain radiographs of the skull and neck showed soft tissue swellings over the
posterior parietal and occipital regions and also the right side of the neck. No calcifications were noted.
Radiograph of the feet showed bilateral valgus deformities and malformed first metatarsals and
hypoplastic proximal phalanges (Figure 2).

Radiograph of the hands showed bilateral hypoplasia of the first metacarpals (Figure 3).

The changes were quite symmetrical on either side. These classic radiological skeletal findings in
association with the fibrous soft tissue masses confirmed the diagnosis of fibrodysplasia ossificans
progressiva.
She has been started on disodium ethydronate 10 mg/kg/day orally for a four months cycle. Her
baseline serum creatinine was 0.4 mg/dl (0.3 - 0.7) and she will be followed up diligently.
Discussion
The initial clinical presentation is appearance of soft tissue swellings on the neck, occiput or back of a
young child. These swellings may regress, subside spontaneously or reoccur or may progress to
ossification. So in early course of the disease the plain radiographic findings of the soft tissue masses
are non specific prior to ossification. It is usually the soft tissue masses that bring the patient to medical
attention.
The first diagnosis in patients with fibrodysplasia ossificans progressiva is often wrong and usually
delayed until ectopic ossification begins. In our case an initial diagnosis of haematoma and some
coagulation disorder was made at another hospital. This delay in the diagnosis could have been due to
failure to recognize the significance of the bilateral abnormal big toes.
On reviewing the past literature it was discovered that many times even ultrasound, CT or the MRI

tindings of the soft tissue masses are non specific prior to ossification5,11 and even the bone scan will
not demonstrate the most acute lesions of fibrodysplasia ossificans progressiva12. In past in many
instances the results of biopsy of an early lesion were misinterpreted as fibromatosis or sarcoma before
the roentgenographic appearance of ossification13. In fact a lesional biopsy is not needed to make the
diagnosis. Biopsy uniformly exacerbates the condition and should be avoided13.
In conclusion, this case emphasizes that the early diagnosis of fibrodysplasia ossificans progressiva is
based on the clinical findings and radiological demonstration of the skeletal malformations, prior to
ossification. The importance of early diagnosis is to potentially save the patient from exposure to
trauma, intramuscular injections, biopsy and operations, as all these can precipitate the lesions and
exacerbate ossification.
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